Subchronic toxicity study of the total flavonoids from Rosa laevigata Michx fruit in rats

Regulatory Toxicology and Pharmacology

Volumn 62, Issue 2, 2012, Pages 221-230

  Zhang, Shuai ^a   Zheng, Lingli ^a   Xu, Lina ^a   Sun, Huijun ^a   Li, Hua ^a   Yao, Jihong ^a   Liu, Kexin ^a   Peng, Jinyong ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

90 day subchronic toxicity; Natural product; NOAEL; Rosa laevigata Michx; Total flavonoids

Indexed keywords

AGLYCONE; ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; FLAVONOID; ISOKAEMPFERIDE; ISORHAMNETIN; PLANT EXTRACT; QUERCETIN; ROSA LAEVIGATA EXTRACT; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADRENAL GLAND; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLOOD ANALYSIS; BODY WEIGHT; CHRONIC TOXICITY; CONTROLLED STUDY; DOSE RESPONSE; ELUTION; FEMALE; FLOW RATE; FLUID INTAKE; FOOD INTAKE; FRUIT; HEART MUSCLE CELL; HEART WEIGHT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROLYSIS; LEUKOCYTE COUNT; MALE; MEDICINAL PLANT; NONHUMAN; ORGAN WEIGHT; PRIORITY JOURNAL; RAT; ROSA LAEVIGATA; SUBCHRONIC TOXICITY; TOXICITY TESTING; URINALYSIS;

ADRENAL GLANDS; ANIMALS; BODY WEIGHT; DRUGS, CHINESE HERBAL; FEMALE; FLAVONOIDS; FRUIT; MALE; ORGAN SIZE; RATS; RATS, SPRAGUE-DAWLEY; ROSA;

RATTUS; ROSA LAEVIGATA;

EID: 84862831271     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2011.12.009     Document Type: Article

References (48)

1. Ajdžanović V., Šošić-Jurjević B., Filipović B., Trifunović S., Manojlović-Stojanoski M., Sekulić M., Milošević V. Genistein-induced histomorphometric and hormone secreting changes in the adrenal cortex in middle-aged rats. Exp. Biol. Med. 2009, 234:148-156.
2. Chen J.M., Li Y.D. Effect of Jinyingzi on experimental passive-Heymann nephritis in rats. Zhong Yao Cai 2005, 28:408-410.
3. Chen J.M., Li Y.D. Effect of Jinyingzi on the acute experimental serum sickness nephritis in rats. LiShiZhen Med. Mat. Med. Res. 2006, 17:1404-1405.
4. Chen N.F., Han B.X., Zhang L., Zhang K. Primary study on HPLC fingerprint of Rosa laevigata Michx (L.) total flavonoids. Anhui Agric. Sci. Bull. 2007, 13:34-35.
5. Chen N.F., Zhang L. Study on the antioxidant property of flavonoid compound in Rosa laevigata Michx. For. By-Prod. Spec. 2005, 5:2-4.
6. Pharmacopoeia of the People's Republic of China, the first division of 2005 edition 2005, China Chemical Industry Press, Beijing, (pp. 153-154). China Pharmacopoeia Committee (Ed.).
7. Cushnie T.P.T., Lamb A.J. Antimicrobial activity of flavonoids. Int. J. Antimicrob. Agents 2005, 26:343-356.
8. Devinsky O., Schachter S.C., Pacia S. Complementary and alternative therapies for epilepsy. Traditional Chinese Medicine 2005, 177-179. Demos Medical Publishing, New York. S.B. Wang, Y.M. Li (Eds.).
9. Dong A.M., Deng L.W. Clinical observation on Shuilu Xiaobai Capsules for proteinuria induced by chronic nephritis. J. New Chin. Med. 2010, 42:49-50.
10. FDA, 2000. FDA Redbook 2000: IV.C.4.a subchronic toxicity studies with rodents.
11. Galati G., O'Brien P.J. Potential toxicity of flavonoids and other dietary phenolics: significance for their chemopreventive and anticancer properties. Free Radic. Biol. Med. 2004, 37:287-303.
12. Giknis M.L.A., Clifford C.B. Clinical laboratory parameters for Crl:CD (SD) rats 2006, Charles River Laboratories, Boston.
13. Harvey A.L. Natural products in drug discovery. Drug Discov. Today 2008, 13:894-901.
14. Harvey P.W., Everett D.J., Springall C.J. Adrenal toxicology: a strategy for assessment of functional toxicity to the adrenal cortex and steroidogenesis. J. Appl. Toxicol. 2007, 27:103-115.
15. Huang X.Q., Liu S.L., Sun X., Zhong H.C., Zhong Z.Y., Wang G. Serum biochemical and prothrombin reference rangers of SPF closed colony SD rat. Chin. J. Comp. Med. 2009, 19:41-43.
16. Huang Y.X., Wang J.J., Zhang X.M. Simultaneously determined of quercetin, luteolin and apigenin in Rosa laevigata by HPLC. Res. Pract. Chin. Med. 2009, 23:32-35.
17. Ito Y., Sørensen K.K., Bethea N.W., Svistounov D., McCuskey M.K., Smedsrød B.H., McCuskey R.S. Age-related changes in the hepatic microcirculation in mice. Exp. Gerontol. 2007, 42:789-797.
18. Jin Y., Xiao Y.S., Zhang F.F., Xue X.Y., Xu Q., Liang X.M. Systematic screening and characterization of flavonoid glycosides in Carthamus tinctorius L. by liquid chromatography/UV diode-array detection/electrospray ionization tandem mass spectrometry. J. Pharm. Biomed. Anal. 2008, 46:418-430.
19. Lam T.P. Strengths and weaknesses of traditional Chinese medicine and Western medicine in the eyes of some Hong Kong Chinese. J. Epidemiol. Community Health 2001, 55:762-765.
20. Lao Y.M., Jiang J.G., Yan L. Application of metabonomic analytical techniques in the modernization and toxicology research of traditional Chinese medicine. Br. J. Pharmacol. 2009, 157:1128-1141.
21. Li Q., Zhang G.J., Feng R., Fu X.H., Mao J.C., Wang Y. Clinical research of diabetic renopathy treated with Tang-an-kang. J. Chengdu Univ. TCM 1999, 22:23-25.
22. Li X., Cao W., Shen Y., Li N., Dong X.P., Wang K.J., Cheng Y.X. Antioxidant compounds from Rosa laevigata fruits. Food Chem. 2012, 130:575-580.
23. Liu Y., Gao Z.X., Li L., Deng T., Luo L.J., Wang H.D. Study on the effect of different extraction methods on rutin and quercetin in Rosa laevigata Michx. J. Anhui Agric. Sci. 2011, 39:4521-4522. p. 4525.
24. Liu Y.T., Lu B.N., Peng J.Y. Hepatoprotective activity of the total flavonoids from Rosa laevigata Michx fruit in mice treated by paracetamol. Food Chem. 2011, 125:719-725.
25. Liu Y.T., Lu B.N., Xu L.N., Yin L.H., Wang X.N., Peng J.Y., Liu K.X. The antioxidant activity and hypolipidemic activity of the total flavonoids from the fruit of Rosa laevigata Michx. Nat. Sci. 2010, 2:175-183.
26. Lu Y., Li J.S., Yan L.J. Potential health impacts of exorbitant flavonoid intake. LiShiZhen Med. Mat. Med. Res. 2009, 20:3079-3081.
27. Min J., Li Y.Y., Yu H. The progress of research on the chemical components, pharmaceutical action and clinical applications of Rosa laevigata Michx. Glob. Chin. Med. 2008, 2:16-18.
28. Nakano T., Sugimoto S., Matsunami K., Otsuka H. Dianthosaponins A-F, triterpene saponins, flavonoid glycoside, aromatic amide glucoside and γ-pyrone glucoside from Dianthus japonicus. Chem. Pharm. Bull. 2011, 59:1141-1148.
29. National Health and Medical Research Council, 2004. Australian code of practice for the care and use of animals for scientific purposes, seventh ed. Australian.
30. National Research Council (US) (Eds.), 2004. International Guiding Principles for Biomedical Research Involving Animals. In: The development of science-based guidelines for laboratory animal care: proceedings of the November 2003 international workshop. National Academies Press, Washington, pp. 240-248.
31. Test guideline 408. Repeated dose 90-day oral toxicity study in rodents. OECD Guidelines for the Testing of Chemicals 1998, OECD, Organisation for Economic Cooperation and Development, Paris.
32. Ohno S., Shinoda S., Toyoshima S., Nakazawa H., Makinoc T., Nakajin S. Effects of flavonoid phytochemicals on cortisol production and on activities of steroidogenic enzymes in human adrenocortical H295R cells. J. Steroid Biochem. Mol. Biol. 2002, 80:355-363.
33. Palm M. The incidence of chronic progressive nephrosis in young Sprague-Dawley rats from two different breeders. Lab. Anim. 1998, 32:477-482.
34. Scalbert A., Williamson G. Dietary intake and bioavailability of polyphenols. J. Nutr. 2000, 130:2073S-2085S.
35. Skibola C.F., Smith M.T. Potential health impacts of excessive flavonoid intake. Free Radic. Biol. Med. 2000, 29:375-383.
36. Su Y.J., Ma J.L., Wang Y.J., Wang H.L. Influence to serum MMP-9 and TIMP-1 levels of a number of Tangshen Capsule in early diabetic nephropathy. Chin. Trad. Pat. Med. 2011, 33:365-366.
37. Wang J.S., Heijden R., Spruit S., Hankermeier T., Chan K., Greef J., Xu G.W., Wang M. Quality and safety of Chinese herbal medicines guided by a systems biology perspective. J. Ethnopharmacol. 2009, 126:31-41.
38. Warren A., Cogger V.C., Fraser R., DeLeve L.D., McCuskey R.S., Couteur D.G.L. The effects of old age on hepatic stellate cells. Curr. Gerontol. Geriatr. Res. 2011, 2011:1-7.
39. Wu X.W., Gao P.Y., Li L.Z., Lu Y., Shen Y., Song S.J., Lin H.W. Studies on the chemical constituents of Rosa laevigata Michx fruits. J. Pharm. Pract. 2009, 27:183-185.
40. Xiang Y.Z., Shang H.C., Gao X.M., Zhang B.L. A Comparison of the Ancient Use of Ginseng in Traditional Chinese Medicine with Modern Pharmacological Experiments and Clinical Trials. Phytother. Res. 2008, 851-858.
41. Xiao K.J., Liu X.H. Chemical compositions and applications of Rosa laevigata Michx fruit. J. Mod. Food Pharm. 2006, 16:1-3.
42. Yamamoto Y., Gaynor R.B. Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer. J. Clin. Invest. 2001, 107:135-142.
43. Zhan S.Q., Yuan D.S., Li X.T., Li J.L., Yin Z.Q. Identification and Determination of Total Flavonoids from Prinsepia utilis Royle. J. Anhui Agric. Sci. 2010, 38:15580-15582. p. 15585.
44. Zhang T.Y., Nie L.W., Wu B.J., Yang Y., Zhao S.S., Jin T. Hypolipedemic activity of the polysaccharose from Rosa laevigata Michx fruit. Chin. J. Pub. Health 2004, 20:829-830.
45. Zhao S.M., Zheng D.X., Huang Y.Y., Lin W.H., Wang Z. Study on the normal reference values of routine blood test, serum biochemical values and values of organ to body weight. Chin. J. Health Lab. Technol. 2002, 12:165-167.
46. Zhao Y.T., Guo X.M., Li F.Z. Antioxidative activity of polysaccharide from Rosa Laevigata Mickx. J. Biol. 2003, 20:23-24.
47. Zhou Y.J., Liao Q.J., Zhang Q.J., Qin Z.Q., Tang H.L., Song Y. Experimental study of Rosa laevigata Mickx in kidney of streptozotocin-induced diabetic rats. J. Nanhua. Univ. (Med. Ed.) 2007, 35:332-335.
48. Zou H.T., Yang Y., Chen S.J. The resource values and prospective of Rosa laevigata Michx fruits as beverage. Sci. Technol. Food Ind. 2006, 27:193-195.